VCV003251891.2 - ClinVar

NM_000497.4(CYP11B1):c.1111G>A (p.Glu371Lys)

Germline

Classification

The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.

(2)

Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.

Likely pathogenic

criteria provided, multiple submitters, no conflicts

Somatic

No data submitted for somatic clinical impact

Somatic

No data submitted for oncogenicity

Variant Details

Identifiers

NM_000497.4(CYP11B1):c.1111G>A (p.Glu371Lys)

Variation ID: 3251891 Accession: VCV003251891.2

Type and length

single nucleotide variant, 1 bp

Location

Cytogenetic: 8q24.3 8: 142875722 (GRCh38) [ NCBI UCSC ] 8: 143957138 (GRCh37) [ NCBI UCSC ]

Timeline in ClinVar

	First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.	Last submission Help The date of the most recent submission for each type of classification for this variant.	Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline	Jul 15, 2024	Jan 25, 2025	May 8, 2024

HGVS

Nucleotide	Protein	Molecular consequence
NM_000497.4:c.1111G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.	NP_000488.3:p.Glu371Lys	missense
NM_001026213.1:c.1111G>A	NP_001021384.1:p.Glu371Lys	missense
NC_000008.11:g.142875722C>T
NC_000008.10:g.143957138C>T
NG_007954.1:g.9099G>A
NG_046132.1:g.1589C>T

... more HGVS ... less HGVS

Protein change

E371K

Other names

Canonical SPDI

NC_000008.11:142875721:C:T

Functional consequence Help The effect of the variant on RNA or protein function, based on experimental evidence from submitters.

Global minor allele frequency (GMAF) Help The global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.

Allele frequency Help The frequency of the allele represented by this VCV record.

Links

VarSome

Genes

Gene	OMIM	ClinGen Gene Dosage Sensitivity Curation		Variation Viewer Help Links to Variation Viewer, a genome browser to view variation data from NCBI databases.	Related variants
Gene	OMIM	HI score Help The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.	TS score Help The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.		Within gene Help The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants.	All Help The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene.
CYP11B1		-	-	GRCh38 GRCh37	229	982
LOC106799833	-	-	-	GRCh38	-	671

Conditions - Germline

Condition Help The condition for this variant-condition (RCV) record in ClinVar.	Classification Help The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions)	Review status Help The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status.	Last evaluated Help The most recent date that a submitter evaluated this variant for the condition.	Variation/condition record Help The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page.
Congenital adrenal hyperplasia	Likely pathogenic (1)	criteria provided, single submitter	Apr 30, 2024	RCV004586335.1
Deficiency of steroid 11-beta-monooxygenase Glucocorticoid-remediable aldosteronism	Likely pathogenic (1)	criteria provided, single submitter	May 8, 2024	RCV005040709.1

Submissions - Germline

Classification Help The submitted germline classification for each SCV record. (Last evaluated)	Review status Help Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria)	Condition Help The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant.	Submitter Help The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar.	More information Help This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter.
Likely pathogenic (Apr 30, 2024)	criteria provided, single submitter (LabCorp Variant Classification Summary - May 2015) Method: clinical testing	Congenital adrenal hyperplasia Affected status: unknown Allele origin: germline	Women's Health and Genetics/Laboratory Corporation of America, LabCorp Accession: SCV005077593.1 First in ClinVar: Jul 15, 2024 Last updated: Jul 15, 2024	Publications: PubMed (1) PubMed: 36929050 Comment: Variant summary: CYP11B1 c.1111G>A (p.Glu371Lys) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging … (more) Variant summary: CYP11B1 c.1111G>A (p.Glu371Lys) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 249438 control chromosomes. c.1111G>A has been reported in the literature in individuals affected with 11B -hydroxylase deficiency (Sun_2023). These data do not allow any conclusion about variant significance. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in negligible enzyme activity when compared to wildtype (Sun_2023). The following publication have been ascertained in the context of this evaluation (PMID: 36929050). No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as likely pathogenic. (less)
Likely pathogenic (May 08, 2024)	criteria provided, single submitter (ACMG Guidelines, 2015) Method: clinical testing	Glucocorticoid-remediable aldosteronism Deficiency of steroid 11-beta-monooxygenase Explanation for multiple conditions: Uncertain. The variant was classified for several related diseases, possibly a spectrum of disease; the variant may be associated with one or more the diseases. Affected status: unknown Allele origin: germline	Fulgent Genetics, Fulgent Genetics Accession: SCV005675073.1 First in ClinVar: Jan 25, 2025 Last updated: Jan 25, 2025

Comment:

Variant summary: CYP11B1 c.1111G>A (p.Glu371Lys) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 249438 control chromosomes. c.1111G>A has been reported in the literature in individuals affected with 11B -hydroxylase deficiency (Sun_2023). These data do not allow any conclusion about variant significance. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in negligible enzyme activity when compared to wildtype (Sun_2023). The following publication have been ascertained in the context of this evaluation (PMID: 36929050). No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as likely pathogenic.

Germline Functional Evidence

There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar.

Comment:

Citations for germline classification of this variant

Title	Author	Journal	Year	Link
Molecular analysis of 12 Chinese patients with 11β-hydroxylase deficiency and in vitro functional study of 20 CYP11B1 missense variants.	Sun B	FASEB journal : official publication of the Federation of American Societies for Experimental Biology	2023	PMID: 36929050

Text-mined citations for this variant ...

Record last updated Feb 01, 2025

ClinVar Genomic variation as it relates to human health

NM_000497.4(CYP11B1):c.1111G>A (p.Glu371Lys)

Variant Details

Genes

Conditions - Germline

Submissions - Germline

Germline Functional Evidence

Citations for germline classification of this variant

Text-mined citations for this variant ...